1.Transfusion-free Management for the Severe Anemia Developed after Nephrectomy.
Minjoo LEE ; Changhyeok HWANG ; Ji Hoon LEE ; Seok Hyung KIM ; Hae Yeul PARK ; Young Goo SONG
The Ewha Medical Journal 2015;38(2):69-71
A 56-year-old woman with emphysematous pyelonephritis underwent an emergent left nephrectomy due to her religious creed. Postoperative hemoglobin level was decreased to 4.4 g/dL from preoperative value of 13.9 g/dL. The patient completely recovered without transfusion and was discharged on the 40th postoperative day without complication.
Anemia*
;
Female
;
Humans
;
Middle Aged
;
Nephrectomy*
;
Pyelonephritis
2.Furosemide induced medullary nephrocalcinosis mimicking Bartter syndrome.
Sohee KIM ; Chanhee KYUNG ; Yong Hoon KIM ; Jang Ho CHO ; Changhyeok HWANG ; Jung Eun LEE
Yeungnam University Journal of Medicine 2014;31(1):21-24
Clinical presentation of Bartter syndrome is similar to surrepitious vomiting or use of diuretics. Therefore, precise differential diagnosis of Bartter syndrome is crucial. We report a case of medullary nephrocalcinosis (MNC) induced by furosemide mimicking Bartter syndrome. A 55-year-old female patient visited our hospital with renal dysfunction on basis of hypokalemia and metabolic alkalosis. She had no history of hypertension or drug use except allopurinol and atorvastatin. She did not complain of nausea or vomiting on presentation and the serum magnesium level was normal. We performed ultrasonography, that showed MNC. For these reasons, we suspected Bartter syndrome and corrected the electrolyte imbalance. During outpatient follow up, we found that the patient had been taking 400 mg of furosemide daily for 30 years. We could diagnose furosemide induced MNC, and recommended to her to reduce the amount of furosemide.
Alkalosis
;
Allopurinol
;
Bartter Syndrome*
;
Diagnosis, Differential
;
Diuretics
;
Female
;
Follow-Up Studies
;
Furosemide*
;
Humans
;
Hypertension
;
Hypokalemia
;
Magnesium
;
Middle Aged
;
Nausea
;
Nephrocalcinosis*
;
Outpatients
;
Ultrasonography
;
Vomiting
;
Atorvastatin Calcium
3.Endoscopic Submucosal Dissection for Recurrent or Residual Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases.
Changhyeok HWANG ; Young Hoon YOUN ; Sung Eun CHOI ; Young Hak JUNG ; Hae Yeul PARK ; Jae Jun PARK ; Jie Hyun KIM ; Hyojin PARK
Clinical Endoscopy 2015;48(6):553-557
We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.
Carcinoma, Squamous Cell
;
Chemoradiotherapy*
;
Endoscopy, Digestive System
;
Esophageal Neoplasms*
;
Follow-Up Studies
;
Humans
;
Middle Aged
;
Recurrence
4.Three Types of Cancer in a Patient with Neurofibromatosis Type I: Gastrointestinal Stromal Tumor, Breast and Ampulla of Vater Cancer.
Hyoeun KIM ; Jae Yong CHO ; Changhyeok HWANG ; Seoyeon YANG ; Youjin CHUN ; Sungmin CHOI ; Sungeun CHOI
Korean Journal of Medicine 2016;90(2):154-158
Neurofibromatosis type 1 (NF-1) is an autosomal dominant disorder with a prevalence of approximately 1 in 3,500 live births. NF-1 predisposes to various benign and malignant neoplasms. Neurological malignancies are most frequent, but the risks of non-nervous system tumors, such as of the esophagus, stomach, colon, liver, biliary tract, pancreas, lung, melanoma, thyroid gland, female breast and ovaries, are also increased. Malignant tumors are the most common cause of death in patients with NF-1. Cases with double primary tumors have been reported, but cases involving three or more primary cancers are rarely reported. Therefore, we present the case of a NF-1 patient diagnosed with gastrointestinal stromal tumor, breast cancer and ampulla of Vater cancer.
Ampulla of Vater*
;
Biliary Tract
;
Breast Neoplasms
;
Breast*
;
Cause of Death
;
Colon
;
Esophagus
;
Female
;
Gastrointestinal Stromal Tumors*
;
Humans
;
Live Birth
;
Liver
;
Lung
;
Melanoma
;
Neurofibromatoses*
;
Neurofibromatosis 1*
;
Ovary
;
Pancreas
;
Prevalence
;
Stomach
;
Thyroid Gland
5.Incidentally Found Chronic Neutrophilic Leukemia in a Patient with Rectal Cancer.
Seok Hyung KIM ; Hae Yeul PARK ; Changhyeok HWANG ; Younghak JUNG ; Minjoo LEE ; Sung Eun CHOI ; Yu Ri KIM
Korean Journal of Medicine 2016;90(1):59-62
Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm characterized by sustained neutrophilia, splenomegaly, and hypercellular bone marrow without Philadelphia chromosome. Diagnosis of CNL requires exclusion of identifiable causes of reactive neutrophilia, such as infection and tumors. Our patient presented with general weakness and weight loss. Computed tomography (CT) showed a mass in the distal rectum, which was confirmed to be an adenocarcinoma by colonoscopic biopsy. Positron emission tomography-CT showed multiple liver, bone, and lymph node metastases. Liver and lymph node biopsies revealed neutrophilic infiltration with no evidence of adenocarcinoma. The pathological findings of the bone marrow were compatible with CNL. Cytogenetic analysis revealed a normal karyotype, and molecular analysis was negative for BCR/ABL. Here, we present a 73 year-old man diagnosed with concurrent CNL and rectal cancer.
Adenocarcinoma
;
Biopsy
;
Bone Marrow
;
Cytogenetic Analysis
;
Diagnosis
;
Electrons
;
Humans
;
Karyotype
;
Leukemia
;
Leukemia, Neutrophilic, Chronic*
;
Leukemoid Reaction
;
Leukocytosis
;
Liver
;
Lymph Nodes
;
Neoplasm Metastasis
;
Neutrophils
;
Philadelphia Chromosome
;
Rectal Neoplasms*
;
Rectum
;
Splenomegaly
;
Weight Loss